# Effects of DPP-4 Inhibition on Triglycerides

> **NCT01527747** · PHASE4 · SUSPENDED · sponsor: **Oregon Health and Science University** · enrollment: 15 (actual)

## Conditions studied

- Type 2 Diabetes
- Hypertriglyceridemia

## Interventions

- **DRUG:** Saxagliptin

## Key facts

- **NCT ID:** NCT01527747
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2012-01
- **Primary completion:** 2024-11
- **Final completion:** 2024-12
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Funding
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527747, "Effects of DPP-4 Inhibition on Triglycerides". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01527747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*